Am J Epidemiol 169 (2009): 489–96.
Whitmer, R. A., et al. “Timing of hormone therapy and dementia: The critical window theory revisited.” Ann Neurol 69 (2011): 163–39.
Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.
Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease, 2008.
Cataldo, J. K., et al. “Cigarette smoking is a risk factor for Alzheimer’s Disease: an analysis controlling for tobacco industry affiliation.” J Alzheimers Dis 19 (2010): 465–80.
Volkow, N. D., et al. “Effects of cell phone radiofrequency signal exposure on brain glucose metabolism.” JAMA 305 (2011): 808–13.
Arendash, G. W., T. Mori, et al. “Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer’s disease mice.” J Alzheim Dis 19 (2010): 191–210.
Kamer, A. R., et al. “Inflammation and Alzheimer’s disease: Possible role of periodontal diseases.” Alzheim Dement 4 (2008): 242–50.
Bates, M. N. “Mercury amalgam dental fillings: an epidemiologic assessment.” Int J Hyg Environ Health 209 (2006): 309–16.
Yücel, M., et al. “Regional brain abnormalities associated with long-term heavy cannabis use.” Arch Gen Psychiatry 65 (2008): 694–701.
Scholes, K. E., and M. T. Martin-Iverson. “Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.” Psychol Med 40 (2010): 1635–46.
Morgan, C. J., et al. “Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.” Br J Psychiatry 197 (2010): 285–90.
Lifshitz, V., et al. “Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.” Neurobiol Aging 1 Mar 2011. http://www.sciencedirect.com/science/article/pii/S019745801100008X.
Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.” J Stroke Cerebrovasc Dis 12 Jan 2011. http://www.sciencedirect. com/science/article/pii/S1052305710002533
McGuinness B, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev 14 Aug 2010 (8): CD007514.
Evans, M. A., and B. A. Golomb. “Statin-associated adverse cognitive effects: survey results from 171 patients.” Pharmacotherapy 29 (2009): 800–11.
Ruitenberg, A., et al. “Incidence of dementia: does gender make a difference?” Neurobiol Aging 22 (2001): 575–80.
Caccamo, A., et al. “Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.” J Biol Chem 185 (2010): 13,107–20.
Kumar, V., and L. J. Kinsella. “Healthy brain aging: effect of head injury, alcohol and environmental toxins.” Clin Geriatr Med 26 (2010): 29–44.
Matser, E.J., et al. “Neuropsychological impairment in amateur soccer players.” JAMA282 (1999): 9071–3.
Voss, M. W., et al. “Plasticity of brain networks in a randomized intervention trial of exercise training in older adults.” Front Aging Neurosci 2 (2010): 1–17.
Gunsted, J., et al. “Improved memory function 12 weeks after bariatric surgery.” Surg Obes Rel Dis 30 Oct 2010.
Brinkworth, G. D., et al. “Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function.” Arch Intern Med 169 (2009): 1873–80.